1. Home
  2. BOXL vs AZTR Comparison

BOXL vs AZTR Comparison

Compare BOXL & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boxlight Corporation

BOXL

Boxlight Corporation

N/A

Current Price

$0.79

Market Cap

3.3M

ML Signal

N/A

Logo Azitra Inc

AZTR

Azitra Inc

N/A

Current Price

$0.22

Market Cap

3.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BOXL
AZTR
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.5M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
BOXL
AZTR
Price
$0.79
$0.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
82.7K
439.7K
Earning Date
04-16-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.06
EPS
N/A
N/A
Revenue
$25,743,612.00
N/A
Revenue This Year
$2.70
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.37
N/A
52 Week Low
$0.50
$0.10
52 Week High
$10.15
$1.40

Technical Indicators

Market Signals
Indicator
BOXL
AZTR
Relative Strength Index (RSI) 37.74 50.71
Support Level $0.71 $0.21
Resistance Level $0.97 $0.23
Average True Range (ATR) 0.07 0.02
MACD 0.01 0.00
Stochastic Oscillator 32.75 71.16

Price Performance

Historical Comparison
BOXL
AZTR

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: